AstraZeneca PLC (AZN)
159.67
+0.03
(+0.02%)
USD |
NYSE |
Sep 11, 15:44
AstraZeneca Gross Profit (TTM) : 44.95B for March 31, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | 44.95B |
| December 31, 2025 | 43.72B |
| September 30, 2025 | 42.54B |
| June 30, 2025 | 41.02B |
| March 31, 2025 | 39.81B |
| December 31, 2024 | 38.96B |
| September 30, 2024 | 37.70B |
| June 30, 2024 | 36.46B |
| March 31, 2024 | 35.14B |
| December 31, 2023 | 33.44B |
| September 30, 2023 | 31.98B |
| June 30, 2023 | 30.60B |
| March 31, 2023 | 28.87B |
| December 31, 2022 | 27.94B |
| September 30, 2022 | 26.95B |
| June 30, 2022 | 24.96B |
| March 31, 2022 | 23.86B |
| December 31, 2021 | 23.06B |
| September 30, 2021 | 22.74B |
| June 30, 2021 | 23.10B |
| March 31, 2021 | 22.82B |
| December 31, 2020 | 22.02B |
| September 30, 2020 | 20.34B |
| June 30, 2020 | 20.32B |
| March 31, 2020 | 19.74B |
| Date | Value |
|---|---|
| December 31, 2019 | 19.35B |
| September 30, 2019 | 20.19B |
| June 30, 2019 | 19.42B |
| March 31, 2019 | 19.34B |
| December 31, 2018 | 18.53B |
| September 30, 2018 | 17.99B |
| June 30, 2018 | 18.43B |
| March 31, 2018 | 17.88B |
| December 31, 2017 | 18.33B |
| September 30, 2017 | 18.19B |
| June 30, 2017 | 18.02B |
| March 31, 2017 | 18.38B |
| December 31, 2016 | 18.91B |
| September 30, 2016 | 19.60B |
| June 30, 2016 | 19.67B |
| March 31, 2016 | 20.46B |
| December 31, 2015 | 20.22B |
| September 30, 2015 | 20.11B |
| June 30, 2015 | 20.39B |
| March 31, 2015 | 20.59B |
| December 31, 2014 | 20.80B |
| September 30, 2014 | 19.99B |
| June 30, 2014 | 19.75B |
| March 31, 2014 | 19.15B |
| December 31, 2013 | 19.14B |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| GSK Plc | 32.65B |
| Johnson & Johnson | 66.63B |
| Eli Lilly & Co. | 66.44B |
| Merck & Co., Inc. | 48.01B |
| Novo Nordisk A/S | 41.49B |